Case file · CIK 0000909661

Farallon Capital Management LLC

Event-driven and multi-strategy long-running sample.

Farallon Capital Management LLCFirm profile
Back to rankings
Card

Q4 2025 · SEC 13F case file

Farallon Capital Management LLC

13F value$21.2BTop themeMixedTop 1046.9%Lines151
#1SPYHedge9.7%
#2RVMDOther5.5%
#3MSFTSoftware5.1%
#4AMZNConsumer4.9%
#5AONOther4.4%

KOL-style case note

This is the public 13F money map for Farallon Capital Management LLC.

Event-driven and multi-strategy long-running sample. This page turns the latest public filing into a shareable research story: what the entity owns, which theme is driving the portfolio, and where to investigate next.

Who this is

Event-driven and multi-strategy long-running sample. It belongs in a smart-money radar because its public 13F shows quarterly capital direction and theme preference.

Top holding

The latest filing's largest public position is SPY, around 9.7% of the disclosed 13F portfolio. That is the first place to look for the current thesis.

Main theme

Mixed is the clearest public theme in the portfolio. The important question is whether that theme repeats across the top positions, not just whether one stock worked.

Portfolio shape

The latest public portfolio is about $21.2B, with 151 lines and roughly 46.9% in the top 10. Higher concentration means a few decisions can explain more of the proxy return.

Why track it

This is not a live trading signal. It is a quarterly capital map: start with the ranking, inspect the top holdings, then ask whether the manager has a repeatable framework.

How to read it

13F filings are delayed and incomplete. They do not show shorts, many derivatives, private positions, cash, or current trade timing. Use this page to generate research questions, not to replace diligence.

Smart Money VelocityVelocity score blends 13F value growth, concentration, theme purity, option exposure, and filing history. It is a prioritization score, not a return.

74
Velocity + theme concentration

Score blends filing growth, concentration, theme purity, call exposure, and filing history.

13F value

$21.2BQ4 2025, latest public filing

Growth since first filing

249.55x$84.9M$21.2B

Reporting lag13F filings arrive after the quarter ends. The page shows a delayed public snapshot, not live positions.

45dQuarter-end snapshot, not live positions
Public Disclosure Proxy Return

This is not actual fund performance. Returns and rankings use public disclosures after they become visible, not private NAV or live trading.

Disclosure workflow

How to read this page

Every number is anchored to a public quarterly filing. The report date is the portfolio snapshot; the filing date is when the market could actually see it.

Report quarterQ4 2025Public filing date2026-02-17Ranking startsafter public filingRanking gate70% price coverageCoverage is the share of eligible public holdings that can be mapped to a ticker and priced. Debt, internal funds, and non-priced lines are excluded from the denominator.

Public holdings

Q4 2025 exposure map

15113F lines
HoldingThemeTypeValue%
SPDR S&P 500 ETF TRSPY · 3,000,000 underlying sharesHedgePUT$2B9.7%
REVOLUTION MEDICINES INCRVMD · 14,582,796 sharesOtherSH$1.2B5.5%
MICROSOFT CORPMSFT · 2,214,079 sharesSoftwareSH$1.1B5.1%
AMAZON COM INCAMZN · 4,499,894 sharesConsumerSH$1B4.9%
AON PLCAON · 2,665,238 sharesOtherSH$940.5M4.4%
NATERA INCNTRA · 3,914,366 sharesOtherSH$896.7M4.2%
BOSTON SCIENTIFIC CORPBSX · 7,439,564 sharesOtherSH$709.4M3.3%
INVESCO EXCHANGE TRADED FD TRSP · 3,600,000 underlying sharesHedgePUT$689.6M3.3%
EXELIXIS INCEXEL · 15,709,500 sharesOtherSH$688.5M3.2%
BRIDGEBIO PHARMA INCBBIO · 8,998,463 sharesSemisSH$688.3M3.2%
ISHARES TRHYG · 8,000,000 underlying sharesHedgePUT$645M3.0%
PROTAGONIST THERAPEUTICS INCPTGX · 6,144,006 sharesOtherSH$536.6M2.5%
WABTECWAB · 2,476,003 sharesOtherSH$528.5M2.5%
UNITEDHEALTH GROUP INCUNH · 1,598,906 sharesOtherSH$527.8M2.5%
CYBERARK SOFTWARE LTDM2682V108 · 1,053,040 sharesSoftwareSH$469.7M2.2%
DISNEY WALT CODIS · 4,125,991 sharesOtherSH$469.4M2.2%
SYNOPSYS INCSNPS · 999,200 sharesSoftwareSH$469.3M2.2%
ELI LILLY & COLLY · 375,000 underlying sharesHedgePUT$403M1.9%
THERMO FISHER SCIENTIFIC INCTMO · 635,685 sharesOtherSH$368.3M1.7%
LANTHEUS HLDGS INCLNTH · 5,427,479 sharesOtherSH$361.2M1.7%
ARAMARKARMK · 9,357,046 sharesOtherSH$344.9M1.6%
SALESFORCE INCCRM · 1,261,177 sharesSoftwareSH$334.1M1.6%
SCHWAB CHARLES CORPSCHW · 3,339,657 sharesOtherSH$333.7M1.6%
CRINETICS PHARMACEUTICALS INCRNX · 6,933,098 sharesSemisSH$322.7M1.5%
BROADCOM INCAVGO · 892,400 sharesSemisSH$308.9M1.5%
LIQUIDIA CORPORATIONLQDA · 8,656,038 sharesOtherSH$298.5M1.4%
NASDAQ INCNDAQ · 2,989,213 sharesOtherSH$290.3M1.4%
BEAM THERAPEUTICS INCBEAM · 10,063,111 sharesOtherSH$278.9M1.3%
KKR & CO INCKKR · 2,017,700 sharesOtherSH$257.2M1.2%
ALPHABET INCGOOG · 787,040 sharesConsumerSH$247M1.2%
MCKESSON CORPMCK · 298,900 sharesOtherSH$245.2M1.2%
VISA INCV · 695,910 sharesOtherSH$244.1M1.2%
NEW YORK TIMES CONYT · 3,280,678 sharesOtherSH$227.7M1.1%
DAYFORCE INC15677J108 · 2,925,000 sharesOtherSH$202.3M0.95%
GRAIL INCGRAL · 2,342,684 sharesOtherSH$200.5M0.95%
BITWISE 10 CRYPTO INDEX ETFBITW · 3,385,500 sharesOtherSH$198.9M0.94%
CBRE GROUP INCCBRE · 983,771 sharesOtherSH$158.2M0.75%
AGIOS PHARMACEUTICALS INCAGIO · 5,159,505 sharesSemisSH$140.4M0.66%
CENTESSA PHARMACEUTICALS PLCCNTA · 5,377,068 sharesSemisSH$134.5M0.63%
BETA BIONICS INCBBNX · 4,313,920 sharesOtherSH$131.4M0.62%
CARDINAL HEALTH INCCAH · 576,000 sharesOtherSH$118.4M0.56%
TANGO THERAPEUTICS INCTNGX · 13,061,411 sharesOtherSH$115.7M0.55%
HIMS & HERS HEALTH INCHIMS · 3,386,986 sharesOtherSH$110M0.52%
ISHARES BITCOIN TRUST ETFIBIT · 2,137,100 sharesDC BitcoinSH$106.1M0.50%
MASTERCARD INCORPORATEDMA · 172,671 sharesOtherSH$98.6M0.47%
CIDARA THERAPEUTICS INC171757206 · 382,800 sharesOtherSH$84.6M0.40%
TENET HEALTHCARE CORPTHC · 372,153 sharesOtherSH$74M0.35%
WELLTOWER INCWELL · 343,000 sharesSemisSH$63.7M0.30%
TRANSUNIONTRU · 675,000 sharesOtherSH$57.9M0.27%
TYRA BIOSCIENCES INCTYRA · 2,066,818 sharesOtherSH$54.3M0.26%
VNET GROUP INCVNET · 6,285,386 sharesOtherSH$53.2M0.25%
ABIVAX SAABVX · 387,000 sharesOtherSH$52.2M0.25%
ENANTA PHARMACEUTICALS INCENTA · 2,772,262 sharesSemisSH$43.7M0.21%
INSMED INCINSM · 250,000 underlying sharesOtherCALL$43.5M0.21%
ASSEMBLY BIOSCIENCES INCASMB · 1,227,590 sharesOtherSH$41.8M0.20%
BAIDU INCBIDU · 315,300 sharesOtherSH$41.2M0.19%
ALNYLAM PHARMACEUTICALS INCALNY · 100,000 underlying sharesHedgePUT$39.8M0.19%
JOYY INCJOYY · 578,200 sharesOtherSH$37.4M0.18%
ISHARES ETHEREUM TRETHA · 1,481,001 sharesOtherSH$33.2M0.16%
STRUCTURE THERAPEUTICS INCGPCR · 454,000 sharesOtherSH$31.6M0.15%
MINERALYS THERAPEUTICS INCMLYS · 823,296 sharesOtherSH$29.9M0.14%
SUNOCOCORP LLCSUNC · 606,277 sharesOtherSH$29.9M0.14%
PERCEPTIVE CAP SOLUTIONS CORG70077105 · 2,250,000 sharesOtherSH$29.3M0.14%
TERNS PHARMACEUTICALS INCTERN · 642,000 sharesSemisSH$25.9M0.12%
ENCOMPASS HEALTH CORPEHC · 234,500 sharesOtherSH$24.9M0.12%
AMKOR TECHNOLOGY INCAMKR · 464,000 sharesOtherSH$18.3M0.09%
VERASTEM INCVSTM · 2,000,000 sharesOtherSH$15.4M0.07%
DOXIMITY INCDOCS · 311,000 sharesOtherSH$13.8M0.06%
GUARDANT HEALTH INCGH · 109,000 sharesOtherSH$11.1M0.05%
MEDLINE INCMDLN · 260,000 sharesOtherSH$10.9M0.05%
NEW ORIENTAL ED & TECHNOLOGY647581206 · 196,000 sharesOtherSH$10.8M0.05%
MINERVA NEUROSCIENCES INCNERV · 2,365,000 sharesOtherSH$9.5M0.04%
GENEDX HOLDINGS CORPWGS · 70,000 sharesOtherSH$9.1M0.04%
GRAYSCALE ETHEREUM MINI TR E38964R203 · 228,340 sharesOtherSH$6.4M0.03%
PRIME MEDICINE INCPRME · 1,240,843 sharesOtherSH$4.3M0.02%
OSCAR HEALTH INCOSCR · 264,000 sharesOtherSH$3.8M0.02%
MADRIGAL PHARMACEUTICALS INCMDGL · 3,319 sharesSemisSH$1.9M0.01%
SUMMIT MIDSTREAM CORPORATIONSMC · 58,214 sharesOtherSH$1.6M0.01%
NOVAVAX INCNVAX · 195,000 sharesOtherSH$1.3M0.01%
SCHRODINGER INCSDGR · 71,000 sharesOtherSH$1.3M0.01%
TEVA PHARMACEUTICAL INDS LTD881624209 · 40,000 sharesSemisSH$1.2M0.01%
CAPRICOR THERAPEUTICS INCCAPR · 41,000 sharesOtherSH$1.2M0.01%
ARROWHEAD PHARMACEUTICALS INARWR · 15,800 sharesSemisSH$1M0.00%
ALVOTECHALVO · 199,675 sharesOtherSH$1M0.00%
BRIGHTSPRING HEALTH SVCS INC10950A106 · 22,000 sharesOtherSH$823.9K0.00%
ROIVANT SCIENCES LTDROIV · 37,000 sharesOtherSH$802.9K0.00%
ARCUTIS BIOTHERAPEUTICS INCARQT · 26,000 sharesOtherSH$755K0.00%
AXSOME THERAPEUTICS INCAXSM · 4,000 sharesOtherSH$730.6K0.00%
COGENT BIOSCIENCES INCCOGT · 17,000 sharesOtherSH$603.8K0.00%
ALKERMES PLCALKS · 20,800 sharesOtherSH$582K0.00%
INSMED INCINSM · 3,000 sharesOtherSH$522.1K0.00%
KRYSTAL BIOTECH INCKRYS · 2,000 sharesOtherSH$493.1K0.00%
PROGYNY INCPGNY · 18,000 sharesOtherSH$462.2K0.00%
TRAVERE THERAPEUTICS INCTVTX · 12,000 sharesOtherSH$458.5K0.00%
HEALTHEQUITY INCHQY · 5,000 sharesOtherSH$458.1K0.00%
CELCUITY INCCELC · 4,000 sharesOtherSH$399K0.00%
OMEROS CORPOMER · 23,000 sharesOtherSH$395K0.00%
IONIS PHARMACEUTICALS INCIONS · 4,800 sharesSemisSH$379.7K0.00%
LIVANOVA PLCLIVN · 6,000 sharesOtherSH$369.2K0.00%
GLOBUS MED INCGMED · 4,000 sharesOtherSH$349.2K0.00%
CENCORA INCCOR · 1,000 sharesOtherSH$337.8K0.00%
UNIQURE NVQURE · 14,000 sharesOtherSH$335K0.00%
BEONE MEDICINES LTDONC · 1,100 sharesOtherSH$334.2K0.00%
CG ONCOLOGY INCCGON · 8,000 sharesOtherSH$332.2K0.00%
SCHOLAR ROCK HLDG CORPSRRK · 7,000 sharesOtherSH$308.4K0.00%
IMMUNOVANT INCIMVT · 12,000 sharesOtherSH$305K0.00%
NUVALENT INCNUVL · 3,000 sharesOtherSH$301.8K0.00%
ASCENDIS PHARMA A/SASND · 1,400 sharesSemisSH$298.5K0.00%
VERACYTE INCVCYT · 7,000 sharesOtherSH$294.7K0.00%
GLAUKOS CORPGKOS · 2,600 sharesOtherSH$293.6K0.00%
SOLID POWER INCSLDP · 405,316 sharesPowerSH$286.9K0.00%
STOKE THERAPEUTICS INCSTOK · 9,000 sharesOtherSH$285.7K0.00%
SABRA HEALTH CARE REIT INCSBRA · 14,000 sharesOtherSH$265.2K0.00%
MERIT MED SYS INC589889104 · 3,000 sharesOtherSH$264.4K0.00%
GRIFOLS S AGRFS · 28,000 sharesOtherSH$261.8K0.00%
ARCELLX INCACLX · 4,000 sharesOtherSH$260.8K0.00%
NUVATION BIO INCNUVB · 29,000 sharesOtherSH$259.8K0.00%
UROGEN PHARMA LTDURGN · 11,000 sharesSemisSH$257.6K0.00%
PACIFIC BIOSCIENCES CALIF IN69404D108 · 135,000 sharesOtherSH$252.5K0.00%
GE HEALTHCARE TECHNOLOGIES IGEHC · 3,000 sharesOtherSH$246.1K0.00%
TWIST BIOSCIENCE CORPTWST · 7,650 sharesOtherSH$242.7K0.00%
MIRUM PHARMACEUTICALS INCMIRM · 3,000 sharesSemisSH$237K0.00%
SOLENO THERAPEUTICS INCSLNO · 5,000 sharesOtherSH$231.5K0.00%
VAXCYTE INCPCVX · 5,000 sharesOtherSH$230.7K0.00%
AMICUS THERAPEUTICS INCFOLD · 16,000 sharesOtherSH$227.8K0.00%
NEOGENOMICS INCNEO · 19,000 sharesOtherSH$223.4K0.00%
ALEANNA INCANNA · 78,400 sharesOtherSH$223.4K0.00%
ICON PLCICLR · 1,200 sharesOtherSH$218.7K0.00%
ESTABLISHMENT LABS HLDGS INCESTA · 3,000 sharesOtherSH$218.6K0.00%
OCULAR THERAPEUTIX INCOCUL · 18,000 sharesOtherSH$218.5K0.00%
SYNDAX PHARMACEUTICALS INCSNDX · 10,000 sharesSemisSH$210.1K0.00%
PRECIGEN INCPGEN · 50,000 sharesOtherSH$209K0.00%
HEALTHCARE RLTY TR42226K105 · 12,000 sharesOtherSH$203.4K0.00%
DYNE THERAPEUTICS INCDYN · 10,000 sharesOtherSH$195.6K0.00%
BIOCRYST PHARMACEUTICALS INCBCRX · 24,000 sharesSemisSH$187.2K0.00%
TVARDI THERAPEUTICS INCTVRD · 43,225 sharesOtherSH$185.9K0.00%
ADAPTIVE BIOTECHNOLOGIES CORADPT · 11,000 sharesOtherSH$178.6K0.00%
ALEANNA INCANNA · 990,000 sharesOtherSH$163.5K0.00%
ARDELYX INCARDX · 23,000 sharesOtherSH$134.1K0.00%
BLUE GOLD LTDBGL · 300,000 sharesOtherSH$132K0.00%
REVOLUTION MEDICINES INCRVMD · 120,085 sharesOtherSH$112.9K0.00%
RANI THERAPEUTICS HLDGS INCRANI · 78,000 sharesOtherSH$105.3K0.00%
ALTIMMUNE INCALT · 27,600 sharesOtherSH$99.6K0.00%
IOVANCE BIOTHERAPEUTICS INCIOVA · 26,000 sharesOtherSH$71K0.00%
GERON CORPGERN · 43,000 sharesOtherSH$56.8K0.00%
EVOLENT HEALTH INCEVH · 14,000 sharesOtherSH$56K0.00%
C4 THERAPEUTICS INCCCCC · 28,000 sharesOtherSH$53.5K0.00%
IRONWOOD PHARMACEUTICALS INCIRWD · 13,000 sharesSemisSH$43.8K0.00%
CANOPY GROWTH CORPCGC · 30,000 sharesOtherSH$34.2K0.00%
NVNI GROUP LIMITEDNVNI · 375,000 sharesOtherSH$22.5K0.00%
BEYOND MEAT INCBYND · 19,000 sharesOtherSH$15.6K0.00%

Quarter tape

Reported 13F value

SEC EDGAR
Q4 2024$84.9MQ1 2025$416.4MQ1 2025$273.9MQ2 2025$482.8MQ2 2025$140.2MQ3 2025$24.4BQ3 2025$24.4BQ4 2025$21.2B

Signal breakdown

Why this matters

74
VelocityVelocity score blends 13F value growth, concentration, theme purity, option exposure, and filing history. It is a prioritization score, not a return.

13F value is 249.55x the first tracked filing.

47
ConcentrationPurity describes how much of the portfolio is concentrated in one inferred theme. It is useful when a manager is expressing a very specific thesis.

Top ten public lines are 46.9% of the latest report.

99
Holdings

151 reportable lines in the latest public filing.

8
History

8 tracked quarterly 13F reports in the database or seed layer.

Publisher mode

Twitter-ready card

Evidence layer

What is public, what is inferred

Public SEC data

13F reports disclose long reportable U.S. securities and long put/call options. They do not show cash, private stakes, shorts, written options, or current live holdings.

Inferred theme

Theme tags are deterministic product analysis from issuer, CUSIP, option type, and keyword rules. They are not SEC labels.

Daily automation

Vercel Cron calls the EDGAR ingestion endpoint every day and records per-manager ingestion results.